Related Experiment Video
Updated: Jul 14, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Differential PIAS3 expression in human malignancy
1Deptartment of Cancer Biology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. wangl@ccf.org
Protein inhibitor of activated STAT3 (PIAS3) regulates protein stability and can induce apoptosis in cancer cells. Increased PIAS3 expression is observed in various human cancers, suggesting its potential as a cancer biomarker.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- STAT3 signaling pathways are crucial in cell regulation.
- PIAS3 (protein inhibitor of activated STAT3) inhibits STAT3 signaling.
- PIAS3 regulates protein stability and function via SUMOylation.
Purpose of the Study:
- To investigate the role of PIAS3 in cancer.
- To determine if PIAS3 expression levels can serve as a cancer biomarker.
Main Methods:
- Studied PIAS3's SUMO ligase activity.
- Examined PIAS3's effect on prostate cancer cell lines (in vitro and in vivo).
- Analyzed endogenous PIAS3 expression in human cancer specimens using immunohistochemistry.
Main Results:
- PIAS3 overexpression induced apoptosis in prostate cancer cells.
- Basal PIAS3 expression was detected in the nucleus of normal epithelial and endothelial cells.
- Elevated PIAS3 expression was found in 100/103 human cancer samples, including lung, breast, prostate, colon-rectum, and brain tumors.
Conclusions:
- PIAS3 plays a role in inducing apoptosis in cancer cells.
- Differential PIAS3 expression patterns in cancer tissues may indicate its utility as a molecular marker for human cancers.
More Related Videos
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...